新诊断胶质母细胞瘤患者神经外科术后接受Stupp方案治疗的免疫标志物:一项回顾性系列研究
这项回顾性研究探讨免疫系统在胶质母细胞瘤(GBM)中的作用,分析95例外周血不同时间点NLR和PLR,并在同一队列31例的福尔马林固定石蜡包埋样本中比较循环与炎症标志物在肿瘤微环境(TME)中的影响。结果显示年龄<60岁和MGMT甲基化者总生存(OS)更好,化疗前全身炎症指数(SII)<480与更好的OS和无进展生存(PFS)相关,仅血管/血管周围区表达的CD68+巨噬细胞和CD66b+中性粒细胞对中位OS和PFS有统计学显著预后作用。作者强调SII可作为Stupp方案反应的预测指标,并建议未来免疫治疗联合研究考虑TME相关标志物。
要点
- 年龄<60岁和MGMT甲基化患者总生存更好。
- 化疗前SII<480与更好的OS和PFS相关。
- 仅血管/血管周围区CD68+巨噬细胞和CD66b+中性粒细胞对中位OS和PFS有统计学显著预后作用。
核心结论
- SII可作为Stupp方案反应的预测指标。
- 关于TME相关标志物,作者建议未来免疫治疗联合研究应考虑免疫浸润亚群表达的每个组分。
研究设计与样本
- 回顾性系列研究。
- 分析95例外周血不同时间点的NLR和PLR。
- 在同一队列31例的福尔马林固定石蜡包埋样本中分析TME标志物。
主要发现
- 年龄<60岁和MGMT甲基化患者总生存更好。
- 化疗前SII<480与更好的OS和PFS相关。
- 仅血管/血管周围区表达的CD68+巨噬细胞和CD66b+中性粒细胞对中位OS和PFS有统计学显著预后作用。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aims of our retrospective study investigated the role of immune system in glioblastoma (GBM), which is the most aggressive primary brain tumor in adults characterized by a poor prognosis. The recurrence rate remains high, probably due to "immune-desert" tumor microenvironment (TME) making GBM hidden from the anti-tumoral immune clearance. Considering this, we aimed to create a panel of prognostic markers from blood and tumor tissue correlating with overall survival (OS) and progression-free survival (PFS). METHODS: Firstly, we analyzed the inflammatory markers NLR and PLR as the ratio of the absolute neutrophil count and absolute platelet count by the absolute lymphocyte count respectively, collected at different time points in the peripheral blood of 95 patients. Furthermore, in 31 patients of the same cohort, we analyzed the formalin-fixed paraffin embedded samples to further compare the impact of circulating and inflammatory markers within the TME. RESULTS: Patients aged < 60 years and with methylated MGMT showed better OS. While, pre-chemotherapy Systemic Inflammatory Index (SII) < 480 was related to a better OS and PFS, we observed that only CD68+macrophage and CD66b+neutrophils expressed in vascular/perivascular area (V) showed a statistically significant prognostic role in median OS and PFS. CONCLUSIONS: Thus, we underscored a role of SII as predictive value of response to STUPP protocol. Regarding the TME-related markers, we suggested to take into consideration for future studies with new immunotherapy combinations, each component relating to expression of immune infiltrating subsets.
引用
- Gurrieri L, Mercatali L, Ibrahim T, et al. Immuno markers in newly diagnosed glioblastoma patients underwent Stupp protocol after neurosurgery: a retrospective series. J Neurooncol. 2023. PMID: 37584750. doi:10.1007/s11060-023-04357-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。